Table 2

Four most prevalent clusters, by sex group (N (women)=217 823; N (men)=191 171)

PrevalencePrevalenceBlocks of diagnosesPrevalence in group‡,Prevalence in cluster,AU P value§
1, %*2, %†%%
WC1¶52.9M50–M54: other dorsopathies35.843.50.79 (0.74–0.85)
82.1F40–F48: neurotic, stress-related and somatoform disorders27.333.2
M70–M79: other soft-tissue disorders27.032.8
N80–N98: non-inflammatory disorders of female genital tract24.229.5
M20–M25: other joint disorders18.622.6
I80–I89: diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified18.322.2
D10–D36: benign neoplasms16.219.7
M15–M19: arthrosis15.719.1
WC223.0E70–E90: metabolic disorders37.463.40.93 (0.86–1.00)
55.8I10–I15: hypertensive diseases25.645.8
E65–E68: obesity and other hyperalimentation19.034.0
E10–E14: diabetes mellitus7.713.7
10.8F10–F19: mental and behavioural disorders due to psychoactive substance use18.739.40.78 (0.73–0.84)
E00–E07: disorders of thyroid gland14.931.4
F30–F39: mood (affective) disorders14.630.8
M80–M85: disorders of bone density and structure11.323.9
WC46.4J00–J06: acute upper respiratory infections12.639.10.71 (0.66–0.77)
32.3K00–K14: diseases of oral cavity, salivary glands and jaws12.137.3
L20–L30: dermatitis and eczema9.328.8
B35–B49: mycoses5.717.8
MC1**50.4E70–E90: metabolic disorders42.250.30.69 (0.64–0.75)
83.8F10–F19: mental and behavioural disorders due to psychoactive substance use33.640.1
I10–I15: hypertensive diseases32.538.8
M50–M54: other dorsopathies27.833.2
E65–E68: obesity and other hyperalimentation14.617.4
E10–E14: diabetes mellitus14.216.9
MC224.2M70–M79: other soft tissue disorders16.929.30.87 (0.84–0.90)
57.6N40–N51: diseases of male genital organs12.121.0
M20–M25: other joint disorders12.120.9
K20–K31: diseases of oesophagus, stomach and duodenum11.520.0
I80–I89: diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified10.017.4
K40–K46: hernia8.815.2
D10–D36: benign neoplasms8.614.9
M15–M19: arthrosis7.713.4
K55–K63: other diseases of intestines6.411.1
MC320.7F40–F48: neurotic, stress-related and somatoform disorders13.524.90.79 (0.74–0.84)
54.1K00–K14: diseases of oral cavity, salivary glands and jaws12.022.3
J40–J47: chronic lower respiratory diseases9.317.2
J00–J06: acute upper respiratory infections8.916.4
J30–J39: other diseases of upper respiratory tract8.014.8
L20–L30: dermatitis and eczema7.513.9
G40–G47: episodic and paroxysmal disorders7.413.7
F50–F59: behavioural syndromes associated with physiological disturbances and physical factors6.612.2
F30–F39: mood (affective) disorders6.311.6
B35–B49: mycoses4.17.6
MC44.7H90–H95: other disorders of ear7.730.60.87 (0.83–0.91)
25.2H53–H54: visual disturbances and blindness3.915.5
B00–B09: viral infections characterised by skin and mucous membrane lesions3.513.9
L60–L75: disorders of skin appendages3.513.9
H10–H13: disorders of conjunctiva3.012.0
H49–H52: disorders of ocular muscles, binocular movement, accommodation and refraction2.811.2
L80–L99: other disorders of the skin and subcutaneous tissue2.510.0
L00–L08: infections of the skin and subcutaneous tissue2.18.3
H00–H06: disorders of eyelid, lacrimal system and orbit1.66.5
  • *Individuals from the strata ≥1 diagnosis in the cluster.

  • †Individuals from the strata with ≥2 diagnosis in the cluster.

  • ‡Strata: same sex.

  • §Approximately unbiased (AU) probability value.

  • ¶Abbreviation of sex, method and number (WC1: women cluster 1).

  • **Abbreviation of sex, method and number (MC1: men cluster 1).